Application of Combined omics Platforms to Accelerate Biomedical Discovery in Diabesity
Application of Combined ‘omics Platforms to Accelerate Biomedical Discovery in Diabesity
The explosive rise in obesity and diabetes (diabesity) threatens the health of many in Western and developing Asian countries. This symposium focuses on the discovery potential of metabolomics and other ‘omics to elucidate the causes and effects.
Organizers: Steven Gross (Weill Cornell Medical College), Irwin Kurland (Albert Einstein College of Medicine), Jennifer Henry (The New York Academy of Sciences)
Speakers: Domenico Accili (Columbia University), Charles Burant (Michigan Nutrition Obesity Research Center), Barbara B. Kahn (Beth Israel Deaconess Medical Center & Harvard Medical School), Irwin Kurland (Albert Einstein College of Medicine), Christopher B. Newgard (Duke University Medical Center)and Gabriele V. Ronnett (Johns Hopkins University School of Medicine)
Panelists: Steven M. Fischer (Agilent Technologies), John Ryals (Metabolon), Mark Sanders (Thermo Fisher Scientific), Joe Shambaugh (Genedata Expressionist), John Shockcor (Waters Corporation)